Statements (51)
| Predicate | Object |
|---|---|
| gptkbp:instance_of |
gptkb:drug
|
| gptkbp:bfsLayer |
7
|
| gptkbp:bfsParent |
gptkb:Desyrel
gptkb:Trazorel |
| gptkbp:activities |
serotonin reuptake inhibitor
|
| gptkbp:approves |
gptkb:FDA
|
| gptkbp:brand |
gptkb:Desyrel
gptkb:Oleptro |
| gptkbp:category |
gptkb:C
|
| gptkbp:complications |
possible
|
| gptkbp:contraindication |
MAO inhibitors
hypersensitivity |
| gptkbp:dosage_form |
150 to 400 mg per day
for insomnia: 25 to 100 mg at bedtime |
| gptkbp:excretion |
urine
|
| https://www.w3.org/2000/01/rdf-schema#label |
trazodone
|
| gptkbp:ingredients |
C19 H22 Cl N5 O
|
| gptkbp:interacts_with |
gptkb:beer
CY P3 A4 inducers CY P3 A4 inhibitors |
| gptkbp:is_atype_of |
N06 A X03
|
| gptkbp:is_available_on |
gptkb:tablet
extended-release tablet |
| gptkbp:is_used_for |
gptkb:historical_event
anxiety insomnia |
| gptkbp:lifespan |
5 to 13 hours
|
| gptkbp:manager |
oral
|
| gptkbp:metabolism |
liver
|
| gptkbp:side_effect |
anxiety
dizziness fatigue headache nausea vomiting confusion seizures restlessness drowsiness insomnia constipation dry mouth weight gain sweating blurred vision tremors agitation serotonin syndrome orthostatic hypotension priapism |
| gptkbp:type_of |
79350-36-0
|